Angelli Bio: Executive Plans to Reduce Holding of 1 Million Shares.

Announcement by Anke Biotechnology: Senior management Yao Jianping, who holds 6.7622 million shares, accounting for 0.40% of the total shares, plans to sell no more than 1 million shares, accounting for 0.06% of the total shares, through centralized bidding or block trading from September 26, 2025 to December 25, 2025. The reason for the sale is personal financial needs, and the shares come from the shares and equity distributed before the company's initial public offering.